183 related articles for article (PubMed ID: 37954130)
1. KYNU as a Biomarker of Tumor-Associated Macrophages and Correlates with Immunosuppressive Microenvironment and Poor Prognosis in Gastric Cancer.
Shen K; Chen B; Yang L; Gao W
Int J Genomics; 2023; 2023():4662480. PubMed ID: 37954130
[TBL] [Abstract][Full Text] [Related]
2. Integrated analysis of single-cell and bulk RNA-sequencing reveals the poor prognostic value of ABCA1 in gastric adenocarcinoma.
Shen K; Ke S; Chen B; Gao W
Discov Oncol; 2023 Oct; 14(1):189. PubMed ID: 37874419
[TBL] [Abstract][Full Text] [Related]
3. Integrated analysis of single-cell and bulk RNA-sequencing data reveals the prognostic value and molecular function of THSD7A in gastric cancer.
Shen K; Chen B; Yang L; Gao W
Aging (Albany NY); 2023 Oct; 15(21):11940-11969. PubMed ID: 37905960
[TBL] [Abstract][Full Text] [Related]
4. Kynureninase Upregulation Is a Prominent Feature of NFR2-Activated Cancers and Is Associated with Tumor Immunosuppression and Poor Prognosis.
León-Letelier RA; Abdel Sater AH; Chen Y; Park S; Wu R; Irajizad E; Dennison JB; Katayama H; Vykoukal JV; Hanash S; Ostrin EJ; Fahrmann JF
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765792
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of biomarkers for epithelial-mesenchymal transition-related cells to estimate the prognosis and immune microenvironment in primary gastric cancer by the integrated analysis of single-cell and bulk RNA sequencing data.
Shen K; Ke S; Chen B; Zhang T; Wang H; Lv J; Gao W
Math Biosci Eng; 2023 Jun; 20(8):13798-13823. PubMed ID: 37679111
[TBL] [Abstract][Full Text] [Related]
6. Kynureninase Promotes Immunosuppression and Predicts Survival in Glioma Patients: In Silico Data Analyses of the Chinese Glioma Genome Atlas (CGGA) and of the Cancer Genome Atlas (TCGA).
Pérez de la Cruz G; Pérez de la Cruz V; Navarro Cossio J; Vázquez Cervantes GI; Salazar A; Orozco Morales M; Pineda B
Pharmaceuticals (Basel); 2023 Feb; 16(3):. PubMed ID: 36986469
[TBL] [Abstract][Full Text] [Related]
7. Elevated TUBA1A Might Indicate the Clinical Outcomes of Patients with Gastric Cancer, Being Associated with the Infiltration of Macrophages in the Tumor Immune Microenvironment.
Wang D; Jiao Z; Ji Y; Zhang S
J Gastrointestin Liver Dis; 2020 Dec; 29(4):509-522. PubMed ID: 33331338
[TBL] [Abstract][Full Text] [Related]
8. A novel copper-induced cell death-related lncRNA prognostic signature associated with immune infiltration and clinical value in gastric cancer.
Wang L; Xiao K; Dong Z; Meng T; Cheng X; Xu Y
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10543-10559. PubMed ID: 37291405
[TBL] [Abstract][Full Text] [Related]
9. Integrated single-cell RNA sequencing analysis reveals a mesenchymal stem cell-associated signature for estimating prognosis and drug sensitivity in gastric cancer.
Shen K; Chen B; Gao W
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11829-11847. PubMed ID: 37410142
[TBL] [Abstract][Full Text] [Related]
10. Prediction and verification of the prognostic biomarker
Zhang W; Zhou D; Song S; Hong X; Xu Y; Wu Y; Li S; Zeng S; Huang Y; Chen X; Liang Y; Guo S; Pan H; Li H
Oncol Lett; 2024 Feb; 27(2):70. PubMed ID: 38192676
[TBL] [Abstract][Full Text] [Related]
11. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
12. High expression of TMEM200A is associated with a poor prognosis and immune infiltration in gastric cancer.
Deng H; Li T; Wei F; Han W; Xu X; Zhang Y
Pathol Oncol Res; 2023; 29():1610893. PubMed ID: 36741965
[No Abstract] [Full Text] [Related]
13. Integrative analysis of cancer-associated fibroblast signature in gastric cancer.
Zhao Z; Mak TK; Shi Y; Li K; Huo M; Zhang C
Heliyon; 2023 Sep; 9(9):e19217. PubMed ID: 37809716
[TBL] [Abstract][Full Text] [Related]
14. SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer.
Li T; Yan Z; Wang W; Zhang R; Gan W; Lv S; Zeng Z; Hou Y; Yang M
Front Mol Biosci; 2021; 8():687319. PubMed ID: 34938771
[No Abstract] [Full Text] [Related]
15. Characterization of the Prognosis and Tumor Microenvironment of Cellular Senescence-related Genes through scRNA-Seq and Bulk RNA-Seq Analysis in GC.
Guo G; Zhou Z; Chen S; Cheng J; Wang Y; Lan T; Ye Y
Recent Pat Anticancer Drug Discov; 2023 Oct; ():. PubMed ID: 37807645
[TBL] [Abstract][Full Text] [Related]
16. INHBB is a novel prognostic biomarker and correlated with immune infiltrates in gastric cancer.
Yu W; He G; Zhang W; Ye Z; Zhong Z; Huang S
Front Genet; 2022; 13():933862. PubMed ID: 36118865
[TBL] [Abstract][Full Text] [Related]
17. GADD45B regulates the carcinogenesis process of chronic atrophic gastritis and the metabolic pathways of gastric cancer.
Xu W; Jiang T; Shen K; Zhao D; Zhang M; Zhu W; Liu Y; Xu C
Front Endocrinol (Lausanne); 2023; 14():1224832. PubMed ID: 37608794
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Analysis of the Expression and Prognosis for ITGBs: Identification of ITGB5 as a Biomarker of Poor Prognosis and Correlated with Immune Infiltrates in Gastric Cancer.
Liu D; Liu S; Fang Y; Liu L; Hu K
Front Cell Dev Biol; 2021; 9():816230. PubMed ID: 35223869
[No Abstract] [Full Text] [Related]
19. Identification of
Wang Y; Fang Y; Zhao F; Gu J; Lv X; Xu R; Zhang B; Fang Z; Li Y
Front Genet; 2022; 13():810292. PubMed ID: 35368661
[TBL] [Abstract][Full Text] [Related]
20. A Novel Autophagy-Related lncRNA Prognostic Signature Associated with Immune Microenvironment and Survival Outcomes of Gastric Cancer Patients.
Chen D; Wang M; Xu Y; Jiang X; Xiong L; Zhang L; Yu H; Xiong Z
Int J Gen Med; 2021; 14():6935-6950. PubMed ID: 34703297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
